Literature DB >> 3877841

Pathophysiology of the kidney in rats with Heymann nephritis.

M J Zamlauski-Tucker, J B Van Liew, B Noble.   

Abstract

Alterations in kidney function were assessed early in the course of Heymann nephritis that was induced in rats by immunization with Fx1A, an extract prepared from rat kidney cortex. Whole kidney and single nephron function were evaluated by clearance and micropuncture techniques. Kidney function was studied in stage 1 of Heymann nephritis, before the onset of proteinuria, and in stage 2, when antibodies are deposited along the brush border of proximal tubules. Although overall kidney function was similar in rats in stage 1 and normal controls, glucose reabsorption was somewhat depressed in the first part of the proximal convoluted tubule in stage 1. Both whole kidney and single nephron glomerular filtration rates were depressed in stage 2. Proteinuria in stage 2 was characterized by an increased albumin sieving coefficient, which resulted in an elevated excretion of albumin. Furthermore, several proximal tubule functions (glucose and fluid reabsorption and PAH extraction) were substantially depressed in stage 2. These findings demonstrate that immunological injury to the proximal tubules in stage 2 of Heymann nephritis produces a significant impairment of proximal function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877841     DOI: 10.1038/ki.1985.157

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

1.  Loss of antigens associated with the apical endocytotic pathway in proximal tubules from rats with heymann nephritis.

Authors:  E J Gutmann; J L Niles; R T McCluskey; D Brown
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

Review 2.  Tubulointerstitial nephritis.

Authors:  C L Jones; A A Eddy
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

3.  Antibody-mediated proliferation of proximal tubule cells requires cross-linking of antigenic determinants.

Authors:  M Brodkin; B Noble
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.